HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ho Tsoi Selected Research

bisamidinium

4/2014Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ho Tsoi Research Topics

Disease

9Neoplasms (Cancer)
02/2022 - 05/2014
9Breast Neoplasms (Breast Cancer)
02/2022 - 01/2018
3Neurodegenerative Diseases (Neurodegenerative Disease)
03/2016 - 05/2011
3Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 05/2014
2Neoplasm Metastasis (Metastasis)
02/2022 - 01/2018
2Carcinogenesis
12/2017 - 01/2015
2Inflammation (Inflammations)
12/2017 - 05/2015
1Triple Negative Breast Neoplasms
11/2021
1Stomach Neoplasms (Stomach Cancer)
10/2016
1Colonic Neoplasms (Colon Cancer)
01/2016
1Myotonic Dystrophy (Dystrophia Myotonica)
04/2014
1Huntington Disease (Huntington's Disease)
06/2013
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
06/2013
1Alzheimer Disease (Alzheimer's Disease)
06/2013

Drug/Important Bio-Agent (IBA)

7TamoxifenFDA LinkGeneric
02/2022 - 01/2018
5Estrogen ReceptorsIBA
02/2022 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2015
3polyglutamineIBA
03/2016 - 05/2011
2CarcinogensIBA
01/2022 - 12/2017
2Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2016
2Anti-Bacterial Agents (Antibiotics)IBA
12/2017 - 01/2017
2AzoxymethaneIBA
12/2017 - 01/2017
2Biological ProductsIBA
10/2016 - 05/2014
2MicroRNAs (MicroRNA)IBA
01/2015 - 05/2014
1reparixinIBA
01/2022
1Interleukin-8 (Interleukin 8)IBA
01/2022
1Androgen Receptors (Androgen Receptor)IBA
01/2022
1human ERBB2 proteinIBA
01/2022
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2022
1Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA
11/2021
1IvabradineIBA
11/2021
1Co-Repressor ProteinsIBA
02/2020
1Eukaryotic Initiation Factor-4EIBA
01/2020
1Estrogens (Estrogen)FDA Link
01/2020
1EpitopesIBA
01/2018
1Drinking WaterIBA
12/2017
1MutagensIBA
12/2017
1CytokinesIBA
12/2017
1Chemokine ReceptorsIBA
12/2017
1Interleukin-17 (Interleukin 17)IBA
12/2017
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
10/2016
1MethyltransferasesIBA
10/2016
1DNA (Deoxyribonucleic Acid)IBA
10/2016
1NucleotidesIBA
03/2016
1Carbonic Anhydrase IVIBA
01/2016
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2016
1Virulence Factors (Pathogenicity Factors)IBA
05/2015
1bisamidiniumIBA
04/2014
1Ribosomal RNAIBA
06/2013
1Glutamine (L-Glutamine)FDA Link
06/2013

Therapy/Procedure

3Therapeutics
01/2022 - 03/2021
1Neoadjuvant Therapy
01/2022